SURAKSHA — Suraksha Diagnostic Income Statement
0.000.00%
- IN₹16.04bn
- IN₹16.33bn
- IN₹2.19bn
Annual income statement for Suraksha Diagnostic, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|
Period Length: | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS |
Standards: | IAS | IAS | IAS |
Status: | Final | Final | Final |
Revenue | |||
Total Revenue | 2,232 | 1,901 | 2,187 |
Cost of Revenue | |||
Gross Profit | 1,573 | 1,560 | 1,846 |
Selling / General / Administrative Expenses | |||
Depreciation and Amortization | |||
Unusual Expense / Income | |||
Other Operating Expenses | |||
Total Operating Expenses | 1,875 | 1,754 | 1,799 |
Operating Profit | 357 | 147 | 388 |
Gain / Loss on Sale of Assets | |||
Total Net Non Operating Interest Income / Expense | |||
Other Net Non Operating Costs | |||
Net Income Before Taxes | 280 | 67.5 | 315 |
Provision for Income Taxes | |||
Net Income After Taxes | 208 | 60.6 | 231 |
Minority Interest | |||
Net Income Before Extraordinary Items | |||
Net Income | 208 | 65.2 | 236 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||
Income Available to Common Shareholders Including Extraordinary Items | |||
Diluted Net Income | 208 | 65.2 | 236 |
Diluted Weighted Average Shares | |||
Basic EPS Including Extraordinary Items | |||
Diluted EPS Including Extraordinary Items | |||
Diluted EPS Excluding Extraordinary Items | |||
Normalised Income Before Taxes | |||
Normalised Income After Taxes | |||
Normalised Income Available to Common Shareholders | |||
Diluted Normalised EPS | 4.2 | 1.67 | 4.95 |
Dividends per Share |